• Categories
  • Archives

Health Council Advises Brazil to Break Patent on Three AIDS Drugs

Brazil should break the patents on three HIV/AIDS drugs, whose cost could jeopardize national anti-HIV efforts, a Brazilian health agency has advised .

The recommendation of the Brazilian National Health Council on August 11 would allow the country to make generic HIV drugs that are much cheaper than their brand name versions.


The council says this year alone Brazil will spend US$ 420 million buying drugs for 136,000 patients. Eighty per cent of this will be spent on three drugs: Lopinavir, made by Abbott Laboratories, Nelfinavir by Merck Sharp and Tenofovir by Gilead.


The high cost of brand-name drugs is threatening the sustainability of the Brazilian Program for the Combat of AIDS, which is widely regarded as a model for fighting HIV/AIDS in developing countries, says the council.


For several months now, the government has been negotiating with the pharmaceutical companies that hold the patents to reduce the price of the three drugs.


Under the internationally agreed TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement, if the nation’s health is at threat, a developing country can invoke a ‘compulsory license’ allowing them to make drugs without paying the patent-holder.


Brazil’s 1996 intellectual property law also allows patents to be broken when companies use exploitative pricing policies.


Brazil threatened three years ago to break Nelfinavir’s patent, but it eventually negotiated a lower price with the drug company. Earlier this year, the country said it would break the patent on Lopinavir, a threat it dropped after Abbott Laboratories agreed to drop the price of the drug from US$ 1.17 to US$ 0.68 for one capsule.


But last week, an announcement from Brazilian public laboratories that they could make the drug for US$ 0.40 kick-started new negotiations.


Because of intense price negotiations and the volume of drugs it buys, Brazil pays far less than other Latin American countries do for HIV/AIDS drugs. For Lopinavir, for example, Mexico pays US$ 2.40 per capsule and Argentina US$ 1.97.


On August 11, the council recommended that Brazil immediately begin producing the drugs locally, strengthen state laboratories and provide more financial resources for research.


It added that any commercial retaliation on the part of the companies against Brazil for breaking the patents should be considered an illegal act.


Council member Carlos Duarte says the Brazilian health ministry has 30 days to approve or suggest changes to the council’s recommendation.


The National Health Council is composed of representatives of consumers, government officials and companies.
 
This article appeared originally in Science and Development Network – www.scidev.net.

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Braziiiiiiiiiil

How could something as apparently benign as a team sport become the greatest unifying ...

Dissecting Brazil’s Zero Hunger

In Brazil, a country of abundance, the existence of mass hunger is a fact ...

Despite Problems Brazil Is Expecting Hefty Crops of Coffee and Soy

The world’s largest producer of soy after the U.S., Brazil, may harvest more of ...

Brazil and Barbados Sign Technical and Cultural Agreements

Brazil’s Minister of Foreign Relations signs today, in Barbados, an agreement for cultural cooperation. ...

Lula Plans to Increase Brazil’s Presence in the US and EU

Curbing inflation, taking legal action against corrupted officials, taking great effort in early foreign ...

Brazilian jail

We Need Jails. Education Alone Won’t Put Brazil Together Again.

Some problems are not solved in isolation. One example of this is the violence, ...

Bare Flesh Protest

To call attention to their gripe, everything is game for the students: to carry ...

Presidential Campaigning Halts While Brazil Mourns Death of a Candidate

The death of Brazil’s presidential candidate Eduardo Campos to the October election has appalled ...

Girl from Ipanema Revisited

We were 2 years into the project of re-translating some classic bossa nova tunes ...

Brazil’s Embraer Deliver 63 Airplanes. 298 Others Have Been Ordered.

Embraer, the Brazilian aircraft manufacturer announced today, July 17, 63 airplanes were delivered in ...